Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of the European Heart Journal and the party authorized to handle such permissions on behalf of the ESC (journals.permissions@oxfordjournals.org). Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
Routine thrombus aspiration before PCI as compared with PCI alone did not reduce 30-day mortality among patients with STEMI. (Funded by the Swedish Research Council and others; ClinicalTrials.gov number, NCT01093404.).
T h e ne w e ngl a nd jou r na l o f m e dicine n engl j med 371;12 nejm
Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.
Рабочая группа по реваскуляризации миокарда Европейского общества кардиологов (esc) и Европейской ассоциации кардиоторакальных хирургов (eActs) Разработаны с участием Европейской ассоциации по чрескожным сердечно-сосудистым вмешательствам (eApcI) Авторы/члены Рабочей группы: stephan Windecker* (Председатель esc) (Швейцария), philippe Kolh* (Председатель eActs) (Бельгия), Fernando Alfonso (Испания), Jean-philippe collet (Франция), Jochen cremer (Германия), Volkmar Falk (Швейцария), Gerasimos Filippatos (Греция), christian Hamm (Германия), stuart J. Head (Нидерланды), peter Jüni (Швейцария), A. pieter Kappetein (Нидерланды), Adnan Kastrati (Германия), Juhani Knuuti (Финляндия), Ulf Landmesser (Швейцария), Günther Laufer (Австрия), Franz-Josef Neumann (Германия), Dimitrios J. Richter (Греция), patrick schauerte (Германия), Miguel sousa Uva (Португалия), Giulio G. stefanini (Швейцария), David paul taggart (Соединённое Королевство), Lucia torracca (Италия), Marco Valgimigli (Италия), William Wijns (Бельгия), and Adam Witkowski (Польша). В подготовке данных рекомендаций приняли участие следующие подразделе-ния esc: Ассоциации esc: Ассоциация специалистов по острой сердечно-сосудистой помощи (Acute cardiovascular care Association; AccA), Европейская ассоциа-ция специалистов по методам визуализации сердечно-сосудистой системы (european Association of cardiovascular Imaging; eAcVI), Европейская ассоциа-ция специалистов по сердечно-сосудистой профилактике и реабилитации (european Association for cardiovascular prevention & Rehabilitation; eAcpR), Европейская ассоциация аритмологов (european Heart Rhythm Association; eHRA), Ассоциация специалистов по сердечной недостаточности (Heart Failure Association; HFA). КомитетРабочие группы esc: Сердечно-сосудистая клеточная электрофизиология, Магнитная резонансная томография сердечно-сосудистой системы, Сер-дечно-сосудистая фармакология и медикаментозная терапия, Сердечно-сосудистая хирургия, Коронарная патофизиология и микроциркуляция, Ядер-ная кардиология и КТ сердца, Периферическая циркуляция, Тромбоз, Коро-нарная болезнь сердца.Советы esc: Кардиологическая практика, Первичная сердечно-сосудистая помощь, Уход за сердечно-сосудистыми больными, Смежные профессии.Содержание данных рекомендаций, подготовленных Европейским Общест-вом Кардиологов (european society of cardiology, esc) опубликовано исклю-чительно для использования в личных и образовательных целях. Не допуска-ется коммерческое использование содержания рекомендаций. Рекомендации esc не могут быть переведены на другие языки либо воспроизведены, полно-стью или частично, без письменного согласия esc. Для получения данного согласия письменная заявка должна быть направлена в oxford University press -организацию, издающую european Heart Journal и официально упол-номоченную esc, рассматривать подобные заявки.Отказ от ответственности. Рекомендации esc отражают взгляды esc и осно-ваны на тщательном анализе научных данных, доступных во время подготовки данных рекомендаций. Медицинским работникам следует придер живаться данных реко...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.